Literature DB >> 30303591

Usefulness of OLGA and OLGIM system not only for intestinal type but also for diffuse type of gastric cancer, and no interaction among the gastric cancer risk factors.

Chang Yong Yun1, Nayoung Kim1,2,3, Jaebong Lee4, Ju Yup Lee1,5, Young Jae Hwang1, Hye Seung Lee6, Hyuk Yoon1,3, Cheol Min Shin1,3, Young Soo Park1,3, Jin-Wook Kim1, Dong Ho Lee1,2,3.   

Abstract

BACKGROUND: The operative link on gastric atrophy (OLGA) and operative link on gastric intestinal metaplasia (OLGIM) stages have been suggested for risk estimation of gastric cancer (GC). However, usefulness of OLGA/OLGIM systems in diffuse type of GC was not investigated so far. The aims of this study were to evaluate the OLGA/OLGIM systems in estimating the GC risk according to Lauren's classification and to investigate the interaction among the risk factors.
MATERIALS AND METHODS: The OLGA/OLGIM stages were evaluated in 1398 (765 control and 633 GC patients) who were prospectively enrolled in the Seoul National University Bundang Hospital. Synergistic interaction among the risk factors for GC was calculated using an additive model.
RESULTS: Among 387 intestinal-type GC patients, 71 (18.3%) were high-risk OLGA stages (III, IV) and 113 (29.2%) were high-risk OLGIM stages (III, IV). Of the 246 patients with diffuse-type GC, 36 (14.6%) were high-risk OLGA stages and 39 (15.9%) were high-risk OLGIM stages. Multivariable analysis revealed family history of GC, Helicobacter pylori infection, high-risk OLGA stages, and high-risk OLGIM stages as independent risk factors for GC regardless of histologic type (odds ratios [ORs] 1.78, 1.94, 2.63, and 3.18, respectively). There was no significant risk modification among the H. pylori infection, family history of GC, and high-risk OLGA/OLGIM stages.
CONCLUSION: High-risk OLGA/OLGIM stages are important prediction markers for GC regardless of H. pylori infection or family history of GC not only for the intestinal type but also for diffuse-type GC.
© 2018 John Wiley & Sons Ltd.

Entities:  

Keywords:  Gastritis; Helicobacter pylori; Metaplasia; Stomach neoplasms

Mesh:

Year:  2018        PMID: 30303591     DOI: 10.1111/hel.12542

Source DB:  PubMed          Journal:  Helicobacter        ISSN: 1083-4389            Impact factor:   5.753


  7 in total

Review 1.  Update on the Diagnosis and Management of Gastric Intestinal Metaplasia in the USA.

Authors:  Judy A Trieu; Mohammad Bilal; Hamzeh Saraireh; Andrew Y Wang
Journal:  Dig Dis Sci       Date:  2019-05       Impact factor: 3.199

Review 2.  The risk of diffuse-type gastric cancer following diagnosis with gastric precancerous lesions: a systematic review and meta-analysis.

Authors:  John E Wang; Sung Eun Kim; Bong Eun Lee; Sungho Park; Joo Ha Hwang; Robert J Huang
Journal:  Cancer Causes Control       Date:  2021-11-19       Impact factor: 2.506

3.  Different effects of p53 protein overexpression on the survival of gastric cancer patients according to Lauren histologic classification: a retrospective study.

Authors:  Ki Wook Kim; Nayoung Kim; Yonghoon Choi; Won Seok Kim; Hyuk Yoon; Cheol Min Shin; Young Soo Park; Dong Ho Lee; Young Suk Park; Sang-Hoon Ahn; Do Joong Park; Hyung-Ho Kim; Hye Seung Lee; Ji-Won Kim; Jin Won Kim; Keun-Wook Lee; Won Chang; Ji Hoon Park; Yoon Jin Lee; Kyoung Ho Lee; Young Hoon Kim
Journal:  Gastric Cancer       Date:  2021-02-18       Impact factor: 7.370

Review 4.  Preventing Metachronous Gastric Cancer after the Endoscopic Resection of Gastric Epithelial Neoplasia: Roles of Helicobacter pylori Eradication and Aspirin.

Authors:  Jiro Watari; Toshihiko Tomita; Katsuyuki Tozawa; Tadayuki Oshima; Hirokazu Fukui; Hiroto Miwa
Journal:  Gut Liver       Date:  2020-05-15       Impact factor: 4.519

5.  Association of MTHFR C677T polymorphism with severity and localization of chronic atrophic gastritis patients without Helicobacter pylori infection: a case control study.

Authors:  Siya Kong; Feng Ye; Yini Dang; Yifei Hua; Guoxin Zhang
Journal:  BMC Cancer       Date:  2020-08-05       Impact factor: 4.430

6.  A Medical Decision Support System to Assess Risk Factors for Gastric Cancer Based on Fuzzy Cognitive Map.

Authors:  Seyed Abbas Mahmoodi; Kamal Mirzaie; Maryam Sadat Mahmoodi; Seyed Mostafa Mahmoudi
Journal:  Comput Math Methods Med       Date:  2020-10-05       Impact factor: 2.238

7.  Severity of gastric intestinal metaplasia predicts the risk of gastric cancer: a prospective multicentre cohort study (GCEP).

Authors:  Jonathan W J Lee; Feng Zhu; Supriya Srivastava; Stephen Kk Tsao; Christopher Khor; Khek Yu Ho; Kwong Ming Fock; Wee Chian Lim; Tiing Leong Ang; Wan Cheng Chow; Jimmy Bok Yan So; Calvin J Koh; Shijia Joy Chua; Andrew S Y Wong; Jaideepraj Rao; Lee Guan Lim; Khoon Lin Ling; Chung-King Chia; Choon Jin Ooi; Andrea Rajnakova; Wai Ming Yap; Manuel Salto-Tellez; Bow Ho; Richie Soong; Kee Seng Chia; Yik Ying Teo; Ming Teh; Khay-Guan Yeoh
Journal:  Gut       Date:  2021-05-11       Impact factor: 23.059

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.